Oruka Therapeutics (ORKA) Selling, General & Administrative (2010 - 2024)
Oruka Therapeutics' Selling, General & Administrative was $2.99 million in Q2 2024, up 74.1% from $1.72 million a year earlier and up 29.1% from the prior quarter.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Selling, General & Administrative (2010 - 2024) Analysis & Trends
On a trailing twelve-month basis, Oruka Therapeutics' Selling, General & Administrative was $8.47 million through Jun 30, 2024, up 37.9% year-over-year; for FY2023, it came in at $6.28 million, up 7.5% from FY2022.
- Selling, General & Administrative has now increased for five consecutive years, with a five-year compound annual growth rate of 10.1% (FY2018 to FY2023).
- In earlier years, Selling, General & Administrative was $5.85 million in FY2022 (+6.3%), $5.5 million in FY2021 (+15.3%), $4.77 million in FY2020 (+19.9%) and $3.98 million in FY2019 (+2.6%).
- The Q2 2024 figure marks the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
- Compared with a year earlier, Selling, General & Administrative has increased for four straight quarters, with growth averaging 22.6% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2020 (growth of 115.0%); the worst was Q4 2022 (a decline of 14.5%).
- Per Business Quant data, ORKA's Selling, General & Administrative in the three quarters before Q2 2024 was $2.32 million (Q1 2024), $1.54 million (Q4 2023) and $1.62 million (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Oruka Therapeutics | 5.31 Bn | 3.37 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 2.99 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.49 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | 1.73 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 1.74 Mn |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | 1.26 Mn |
| Mar 31, 2021 | 1.23 Mn |
| Dec 31, 2020 | 1.92 Mn |
| Sep 30, 2020 | 939,000.00 |
| Jun 30, 2020 | 938,000.00 |
| Mar 31, 2020 | 975,000.00 |
| Dec 31, 2019 | 894,000.00 |
| Sep 30, 2019 | 900,000.00 |
API Access
Oruka Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ORKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();